Nuwellis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Nuwellis, Inc. (Nasdaq: NUWE) on June 3, 2022, reporting an event that occurred on May 31, 2022. The filing addresses a regulatory notice regarding the company's continued listing status on the Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the stock price performance triggering the regulatory notice: the closing bid price for the Company's common stock was below $1.00 for 30 consecutive trading days.
Material Changes
The material change reported is the receipt of a formal Notice from the Nasdaq Listing Qualifications Department stating the Company is not in compliance with the Minimum Bid Price Requirement (Nasdaq Marketplace Rule 5550(a)(2)). This deficiency is based on the sustained low stock price mentioned above.
Outlook, Risks, and Management Commentary
- Compliance Period: The Company has 180 calendar days from May 31, 2022, until November 28, 2022, to regain compliance.
- Path to Compliance: Compliance can be achieved if the closing bid price reaches or exceeds $1.00 per share for a minimum of 10 consecutive trading days before the deadline.
- Extension Options: If the Company fails to regain compliance by November 28, 2022, it may be eligible for an additional 180-day period. This requires meeting the market value of publicly held shares requirement and all other initial listing standards, potentially necessitating a reverse stock split.
- Risks: There is no assurance the Company will regain compliance, secure an extension, or maintain other listing requirements. Failure to cure the deficiency could result in delisting.
- Management Action: The Company intends to actively monitor the stock price and consider available options to resolve the deficiency.
Investor Verification Checklist
- Verify the current closing bid price of Nuwellis common stock to assess proximity to the $1.00 threshold.
- Monitor the stock price for 10 consecutive trading days at or above $1.00 to confirm potential resolution of the deficiency.
- Review future filings for announcements regarding a potential reverse stock split if the initial compliance period expires without resolution.
- Check for any subsequent Nasdaq notices regarding the denial of an extension or the initiation of delisting proceedings.